Avanos Medical (AVNS)
(Delayed Data from NYSE)
$18.10 USD
+0.25 (1.40%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $18.09 -0.01 (-0.06%) 7:58 PM ET
4-Sell of 5 4
A Value D Growth B Momentum B VGM
Cash flow Statements
Fiscal Year End for AVANOS MEDICAL, INC falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -61.80 | 50.50 | 5.20 | -27.20 | -45.90 |
Depreciation/Amortization & Depletion | 46.10 | 47.70 | 38.30 | 42.90 | 36.90 |
Net Change from Assets/Liabilities | -18.00 | -24.30 | 26.00 | -67.80 | -59.60 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 66.10 | 17.00 | 17.80 | 49.60 | -5.90 |
Net Cash From Operating Activities | 32.40 | 90.90 | 87.30 | -2.50 | -74.50 |
Property & Equipment | -17.80 | -19.30 | -21.00 | -20.20 | -50.60 |
Acquisition/ Disposition of Subsidiaries | 39.40 | -116.10 | 0.00 | -4.00 | -57.50 |
Investments | 0.00 | 0.00 | 0.00 | -4.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 21.60 | -135.40 | -21.00 | -24.20 | -108.10 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -17.80 | -43.80 | -5.30 | 2.50 | 1.70 |
Issuance (Repayment) of Debt | -64.70 | 103.40 | -50.00 | -69.80 | -0.20 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -11.70 | -2.90 | 0.00 | -2.70 | 0.00 |
Net Cash from Financing Activities | -94.20 | 56.70 | -55.30 | -70.00 | 1.50 |
Effect of Exchange Rate Changes | 0.20 | -3.00 | -4.00 | 2.90 | 1.90 |
Net Change In Cash & Equivalents | -40.00 | 9.20 | 7.00 | -93.80 | -179.20 |
Cash at Beginning of Period | 127.70 | 118.50 | 111.50 | 205.30 | 384.50 |
Cash at End of Period | 87.70 | 127.70 | 118.50 | 111.50 | 205.30 |
Diluted Net EPS | -1.32 | 1.07 | 0.11 | -0.57 | -0.96 |
Fiscal Year End for AVANOS MEDICAL, INC falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -61.80 | -72.30 | -68.60 | -0.50 |
Depreciation/Amortization & Depletion | NA | 46.10 | 93.70 | 82.70 | 12.10 |
Net Change from Assets/Liabilities | NA | -18.00 | -12.10 | -32.70 | -19.30 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 66.10 | 10.40 | 9.20 | 0.90 |
Net Cash From Operating Activities | NA | 32.40 | 19.70 | -9.40 | -6.80 |
Property & Equipment | NA | -17.80 | -11.90 | -8.00 | -4.00 |
Acquisition/ Disposition of Subsidiaries | NA | 39.40 | -47.50 | -2.50 | 0.00 |
Investments | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | 21.60 | -59.40 | -10.50 | -4.00 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | -17.80 | -11.40 | -3.10 | -0.50 |
Issuance (Repayment) of Debt | NA | -64.70 | 31.90 | -23.10 | -21.60 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | -11.70 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | NA | -94.20 | 20.50 | -26.20 | -22.10 |
Effect of Exchange Rate Changes | NA | 0.20 | -1.40 | 0.20 | 0.90 |
Net Change In Cash & Equivalents | NA | -40.00 | -20.60 | -45.90 | -32.00 |
Cash at Beginning of Period | NA | 127.70 | 127.70 | 127.70 | 127.70 |
Cash at End of Period | NA | 87.70 | 107.10 | 81.80 | 95.70 |
Diluted Net EPS | NA | 0.23 | -0.08 | -1.46 | -0.01 |